Interní Med. 2016; 18(1): 43-45 | DOI: 10.36290/int.2016.011

Relapsing Salmonella-sepsis in an immunocompromised host

MUDr. Pavel Polák, Ph.D.1,2,3,4, prof. MUDr. Petr Husa, CSc.1,2, MUDr. Miloš Keřkovský, Ph.D.1
1 Oddělení klinické hematologie, Fakultní nemocnice Brno
2 Klinika infekčních chorob, Fakultní nemocnice Brno
3 Klinika interní, geriatrická, ošetřovatelství a praktického lékařství, Fakultní nemocnice Brno
4 Lékařská fakulta Masarykovy univerzity Brno
5 Radiologická klinika, Fakultní nemocnice Brno

The authors present a clinical case of a secondary relapsing Salmonella-sepsis in a patient with systemic lupus erythematodes. A multilevel spondylodiscitis with paravertebral abscesses as a cause of the disease was diagnosed. The choice of antibiotics was complicated by allergy to co-trimoxazole and manifestations of postantibiotic colitis during the ciprofloxacin treatment. Meropenem and doxycyclin were used in the treatment without any other complications.

Keywords: Salmonella enteritidis, secondary sepsis, disturbed immune system

Published: February 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Polák P, Husa P, Keřkovský M. Relapsing Salmonella-sepsis in an immunocompromised host. Interní Med. 2016;18(1):43-45. doi: 10.36290/int.2016.011.
Download citation

References

  1. Žemličková H, Dědičová D, Jakubů V, et al. Antibiotická rezistence u netyfových sérovarů Salmonella spp. v České republice. Epidemiol Mikrobiol Imunol 2013; 62(2): 43-49.
  2. Feasey NA, Dougan G, Kingsley RA, et al. Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa. Lancet 2012; 379(9835): 2489-2499. Go to original source...
  3. Gordon MA. Invasive nontyphoidal Salmonella disease: epidemiology, pathogenesis and diagnosis. Curr Opin Infect Dis 2011; 24(5): 484-489. Go to original source...
  4. Hsu RB, Tsay YG, Chen RJ, et al. Risk factors for primary bacteremia and endovascular infection in patients without acquired immunodeficiency syndrome who have nontyphoid salmonellosis. Clin Infect Dis 2003; 36(7): 829-834. Go to original source... Go to PubMed...
  5. Laupland KB, Sch?nheyder HC, Kennedy KJ, et al. Salmonella enterica bacteraemia: a multi-national population-based cohort study. BMC Infect Dis 2010; 10(95): 1-6. Go to original source...
  6. Parry CM, Thomas S, Aspinall EJ, et al. A retrospective study of secondary bacteraemia in hospitalised adults with community acquired non-typhoidal Salmonella gastroenteritis. BMC Infect Dis 2013; 13(107): 1-10. Go to original source...
  7. Weinberger M, Andorn N, Agmon V, et al. Blood invasiveness of Salmonella enterica as a function of age and serotype. Epidemiol Infect 2004; 132(6): 1023-1028. Go to original source... Go to PubMed...
  8. Kotalová R. Léčba akutních gastroenteritid. Postgrad Med 2010; 12(Suppl. 2): 6-15.
  9. Onwuezobe IA, Oshun PO, Odigwe CC. Antimicrobials for treating symptomatic non-typhoidal Salmonella infection. Cochrane Database Syst Rev 2012; 11: CD001167. Go to original source... Go to PubMed...
  10. Sánchez-Vargas FM, Abu-El-Haija MA, Gómez-Duarte OG. Salmonella infections: an update on epidemiology, management, and prevention. Travel Med Infect Dis 2011; 9(6): 263-277. Go to original source...
  11. Cottle L, Riordan T. Infectious spondylodiscitis. J Inf 2008; 56: 401-412. Go to original source... Go to PubMed...
  12. Müller EJ, Russe OJ, Muhr G. Osteomyelitis der Wirbelsäule. Orthopäde 2004; 33: 305-315. Go to original source... Go to PubMed...
  13. Sobottke R, Seifert H, Fätkenheuer G, et al. Aktuelle Diagnostik un Therapie der Spondylodiszitis. Dtsch Aerzteblatt 2008; 105(10): 181-187.
  14. Société de pathologie infectieuse de langue francaise. Recommandations pour la pratique clinique: spondylodiscites infectieuses primitives, et secondaires ? un geste intradiscal, sans mise en place de materiel. Med et mal infectieuses 2007; 37: 573-583.
  15. Zeller V, Desplaces N. Antibiothérapie des infections osteoarticulaires ? pyog?nes chez l'adulte: principes et modalités. Rev du Rhumatisme 2006; 73: 183-190. Go to original source...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.